Holen Sie sich die Stockscreener-App
124.41
1.98%
2.41
Handel nachbörslich:
124.43
0.02
+0.02%
Schlusskurs vom Vortag:
$122.00
Offen:
$121.81
24-Stunden-Volumen:
470.74K
Relative Volume:
0.74
Marktkapitalisierung:
$6.21B
Einnahmen:
$338.46M
Nettoeinkommen (Verlust:
$-310.96M
KGV:
-19.05
EPS:
-6.53
Netto-Cashflow:
$-132.82M
1W Leistung:
+2.18%
1M Leistung:
+16.77%
6M Leistung:
-0.92%
1J Leistung:
+30.19%
1-Tages-Spanne:
$121.75
$124.52
1-Wochen-Bereich:
$119.93
$124.61
52-Wochen-Spanne:
$75.56
$139.13
Axsome Therapeutics Inc Stock (AXSM) Company Profile
Firmenname
Axsome Therapeutics Inc
Sektor
Branche
Telefon
(212) 332-3241
Adresse
ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK
Vergleichen Sie AXSM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AXSM
Axsome Therapeutics Inc
|
124.41 | 6.16B | 338.46M | -310.96M | -132.82M | -6.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Axsome Therapeutics Inc Stock (AXSM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-03 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-06-03 | Eingeleitet | Oppenheimer | Outperform |
| 2025-04-07 | Eingeleitet | Jefferies | Buy |
| 2025-02-11 | Eingeleitet | Deutsche Bank | Buy |
| 2024-12-31 | Bestätigt | Mizuho | Outperform |
| 2024-09-03 | Eingeleitet | Wells Fargo | Overweight |
| 2024-08-06 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-07-22 | Eingeleitet | Needham | Buy |
| 2024-04-29 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-03-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-02-06 | Eingeleitet | UBS | Buy |
| 2024-01-25 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-12-13 | Eingeleitet | Citigroup | Buy |
| 2023-08-08 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-01-05 | Eingeleitet | Piper Sandler | Neutral |
| 2022-11-01 | Eingeleitet | Loop Capital | Buy |
| 2022-09-07 | Fortgesetzt | Mizuho | Buy |
| 2021-08-10 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-10 | Eingeleitet | Berenberg | Buy |
| 2021-01-08 | Eingeleitet | Jefferies | Buy |
| 2020-12-16 | Eingeleitet | Mizuho | Buy |
| 2020-09-29 | Eingeleitet | BofA Securities | Underperform |
| 2020-09-10 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-04-28 | Bestätigt | H.C. Wainwright | Buy |
| 2020-04-14 | Eingeleitet | Cowen | Outperform |
| 2019-12-30 | Bestätigt | H.C. Wainwright | Buy |
| 2019-12-17 | Bestätigt | H.C. Wainwright | Buy |
| 2019-12-16 | Bestätigt | Guggenheim | Buy |
| 2019-10-16 | Eingeleitet | Guggenheim | Buy |
| 2019-09-18 | Eingeleitet | William Blair | Outperform |
| 2019-05-28 | Eingeleitet | SunTrust | Buy |
| 2019-05-23 | Bestätigt | H.C. Wainwright | Buy |
| 2019-04-08 | Eingeleitet | SVB Leerink | Outperform |
| 2019-03-15 | Bestätigt | H.C. Wainwright | Buy |
| 2016-10-03 | Fortgesetzt | Brean Capital | Buy |
| 2015-12-15 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2015-12-14 | Eingeleitet | Ladenburg Thalmann | Buy |
Alle ansehen
Axsome Therapeutics Inc Aktie (AXSM) Neueste Nachrichten
Axsome at Wells Fargo Conference: Growth and Strategic Expansions - Investing.com
214,139 Shares in Axsome Therapeutics, Inc. $AXSM Acquired by Driehaus Capital Management LLC - MarketBeat
Axsome initiated with Overweight at Wells Fargo on Alzheimer's drug potential - MSN
Wells Fargo Initiates Axsome Therapeutics with Overweight Rating, $163 Price Target - AInvest
Axsome Therapeutics Insider Sold Shares Worth $7,303,400, According to a Recent SEC Filing - 富途牛牛
Why Is Axsome (AXSM) Up 19.2% Since Last Earnings Report? - Yahoo Finance
Will Axsome Therapeutics Inc. stock recover after recent dropEarnings Trend Report & Technical Buy Zone Confirmation - Newser
What to do if you’re stuck in Axsome Therapeutics Inc.Watch List & Safe Capital Investment Plans - Newser
Best data tools to analyze Axsome Therapeutics Inc. stock2025 Institutional Moves & Free Weekly Chart Analysis and Trade Guides - Newser
What’s the recovery path for long term holders of Axsome Therapeutics Inc.2025 EndofYear Setup & Free Expert Verified Stock Movement Alerts - Newser
Axsome Therapeutics stock rated Overweight by Wells Fargo - Investing.com Australia
PDT Partners LLC Purchases 47,004 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat
Forecasting Axsome Therapeutics Inc. price range with options dataQuarterly Profit Review & AI Based Buy and Sell Signals - Newser
Ranking Axsome Therapeutics Inc. among high performing stocks via toolsRate Cut & Weekly Chart Analysis and Trade Guides - Newser
Axsome Therapeutics, Inc. $AXSM Shares Sold by Russell Investments Group Ltd. - MarketBeat
Published on: 2025-09-03 05:51:54 - Newser
Point72 Europe London LLP Cuts Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Tema Etfs LLC Takes Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Chart based analysis of Axsome Therapeutics Inc. trendsCPI Data & Weekly Top Performers Watchlists - Newser
What’s next for Axsome Therapeutics Inc. stock price2025 Market WrapUp & Expert-Curated Trade Recommendations - Newser
Why Axsome Therapeutics Inc. is moving todayCEO Change & Smart Money Movement Alerts - Newser
Applying big data sentiment scoring on Axsome Therapeutics Inc.2025 Market Trends & Detailed Earnings Play Strategies - Newser
What earnings revisions data tells us about Axsome Therapeutics Inc.Trade Signal Summary & Daily Oversold Stock Bounce Ideas - Newser
Published on: 2025-09-03 02:19:56 - Newser
Northern Trust Corp Buys 8,469 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Therapeutics, Inc. $AXSM is Tri Locum Partners LP's 7th Largest Position - MarketBeat
What does recent volatility data suggest for Axsome Therapeutics Inc.Market Growth Summary & Scalable Portfolio Growth Methods - Newser
Axsome therapeutics director Jeffs sells $1.66 million in stock - Investing.com
Axsome Therapeutics Director JEFFS ROGER Sells 13,464 Shares at $123.68. - AInvest
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
Published on: 2025-09-03 01:34:58 - khodrobank.com
Axsome Therapeutics shares rise 1.58% intraday after insider sold shares. - AInvest
Order flow analysis tools used on Axsome Therapeutics Inc.2025 Earnings Surprises & Fast Momentum Entry Tips - Newser
Applying chart zones and confluence areas to Axsome Therapeutics Inc.July 2025 EndofMonth & Pattern Based Trade Signal System - Newser
Landscape Capital Management L.L.C. Makes New $632,000 Investment in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Shares Up 20% in a Month: How Should You Play the Stock? - MSN
Momentum divergence signals in Axsome Therapeutics Inc. chartDip Buying & Reliable Entry Point Alerts - Newser
Raymond James Financial Inc. Cuts Stock Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Therapeutics: Fortifying Market Dominance Through Strategic Patent Portfolios and Franchise Resilience - AInvest
H.C. Wainwright Reaffirms Buy on Axsome (AXSM) Following Generic Challenge to Portfolio - Yahoo Finance
Can Axsome Therapeutics Inc. recover in the next quarterJuly 2025 Trade Ideas & Long-Term Growth Portfolio Plans - Newser
US Stocks Recap: Is Axsome Therapeutics Inc. subject to activist investor interestJuly 2025 Weekly Recap & Technical Pattern Based Signals - خودرو بانک
Can Axsome Therapeutics Inc. continue delivering strong returnsJuly 2025 Sentiment & Fast Entry High Yield Tips - خودرو بانک
FORA Capital LLC Buys Shares of 7,633 Axsome Therapeutics, Inc. $AXSM - MarketBeat
Can technical indicators confirm Axsome Therapeutics Inc.’s reversalChart Signals & Verified Technical Signals - Newser
Published on: 2025-09-01 11:39:02 - Newser
Is now a turning point for Axsome Therapeutics Inc.2025 Performance Recap & AI Powered Buy and Sell Recommendations - Newser
Axsome Therapeutics Inc.’s volatility index tracking explainedJuly 2025 Summary & Free Technical Confirmation Trade Alerts - Newser
Quantitative Investment Management LLC Takes Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Affinity Asset Advisors LLC Increases Stock Position in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q2 2025 Earnings Call Transcript - MSN
Finanzdaten der Axsome Therapeutics Inc-Aktie (AXSM)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):